2021
DOI: 10.1016/j.ijcard.2020.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Impact of malignancy on clinical outcomes in patients with acute coronary syndromes

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…ACS are associated with significantly higher mortality and morbidity rates in cancer patients than in their non-cancer counterparts [ 51 ]. Yousif et al, in their prospective study, reported a higher all-cause mortality rate at 12 months, 30.3% in cancer vs. 11.9% in non-cancer patients, p < 0.0001, along with a higher incidence of net adverse clinical events, 33.9% in cancer patients vs. 19.8% in non-cancer patients, p < 0.001 [ 52 ]. Mrtozek et al showed that troponin-positive ACS (HR 2.365 [1.162–4.817], p = 0.018) was most predictive of mortality in cancer patients presenting with ACS.…”
Section: Approach To Coronary Artery Disease Diagnosis and Managementmentioning
confidence: 99%
“…ACS are associated with significantly higher mortality and morbidity rates in cancer patients than in their non-cancer counterparts [ 51 ]. Yousif et al, in their prospective study, reported a higher all-cause mortality rate at 12 months, 30.3% in cancer vs. 11.9% in non-cancer patients, p < 0.0001, along with a higher incidence of net adverse clinical events, 33.9% in cancer patients vs. 19.8% in non-cancer patients, p < 0.001 [ 52 ]. Mrtozek et al showed that troponin-positive ACS (HR 2.365 [1.162–4.817], p = 0.018) was most predictive of mortality in cancer patients presenting with ACS.…”
Section: Approach To Coronary Artery Disease Diagnosis and Managementmentioning
confidence: 99%